A novel nanoparticle-based theranostic agent targeting low-density lipoprotein receptor-related protein-1 enhances the efficacy of neoadjuvant radiotherapy in colorectal cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Kyoung Jin | - |
dc.contributor.author | Park, Serk In | - |
dc.contributor.author | Jeong, Seong-Yun | - |
dc.contributor.author | Choi, Eun Kyung | - |
dc.date.accessioned | 2021-09-02T09:52:29Z | - |
dc.date.available | 2021-09-02T09:52:29Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2018-07 | - |
dc.identifier.issn | 0008-5472 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/74844 | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | AMER ASSOC CANCER RESEARCH | - |
dc.title | A novel nanoparticle-based theranostic agent targeting low-density lipoprotein receptor-related protein-1 enhances the efficacy of neoadjuvant radiotherapy in colorectal cancer | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Serk In | - |
dc.identifier.doi | 10.1158/1538-7445.AM2018-3702 | - |
dc.identifier.wosid | 000468819501493 | - |
dc.identifier.bibliographicCitation | CANCER RESEARCH, v.78, no.13 | - |
dc.relation.isPartOf | CANCER RESEARCH | - |
dc.citation.title | CANCER RESEARCH | - |
dc.citation.volume | 78 | - |
dc.citation.number | 13 | - |
dc.type.rims | ART | - |
dc.type.docType | Meeting Abstract | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.